Glaxo to share malaria drug data

Pharmaceutical giant GlaxoSmithKline (GSK) will release 13,500 malaria drug candidates into the public domain as part of its ‘open innovation’ agenda, it announced on 20 January 2010. Chief executive Andrew Witty outlined the company’s strategy for increasing its intellectual property flexibility and altering its business model to tackle neglected tropical diseases. “We’re trying to identify […]

Read More Glaxo to share malaria drug data

Biotech industry can help tackle neglected diseases

Biotech industry can help tackle neglected diseases Source: Nature Biotechnology 17 April 2009 | EN Biotech can inject innovation into neglected-disease product development Argonne National Laboratory/Flickr The biotech industry provides rich resources and expertise that could help tackle neglected diseases, say Joanna E. Lowell and Christopher D. Earl from BIO Ventures for Global Health in […]

Read More Biotech industry can help tackle neglected diseases